Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Lynn M. Billingsley"'
Autor:
Cecil O. Samuelson, Graciela S. Alarcón, Richard P. Polisson, H. James Williams, Stephen L. Dahl, Marlene J. Egger, John R. Ward, Steven R. Weiner, Maria Guttadauria, Robert F. Willkens, Michael E. Luggen, Lynn M. Billingsley, James C. Reading, Cheryl Yarboro
Publikováno v:
Arthritis & Rheumatism. 28:721-730
One hundred eighty-nine patients with rheumatoid arthritis were entered into a prospective, controlled, double-blind multicenter trial comparing placebo and methotrexate (MTX). One hundred ten patients completed 18 weeks of therapy. No remissions wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b4b66ae0756d69000ce3350ff57d1a5
https://doi.org/10.1002/art.1780280702
https://doi.org/10.1002/art.1780280702
Autor:
Lynn M. Billingsley, Lillian Szydlo, John H. Klippel, Graciela S. AlarcOan, William J. Koopman, Joyce Z. Singer, Ronald T. Acton, Bruce O. Barger, Joe G. Hardin, Daniel O. Clegg, Richard P. Polisson, Michael E. Luggen, Stephen L. Dahl, Robert F. Willkens
Publikováno v:
Arthritis & Rheumatism. 30:218-220
Recent studies have indicated an association between the HLA-DR2 phenotype and substantial response to methrotrexate in patients with rheumatoid arthritis (RA). To further resolve this issue, we analyzed this relationship. Our data, obtained from a m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ea941f209f4fcb8b1c805194dc41788
https://doi.org/10.1002/art.1780300213
https://doi.org/10.1002/art.1780300213